<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="125594">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01467453</url>
  </required_header>
  <id_info>
    <org_study_id>Triggerfisch-001</org_study_id>
    <nct_id>NCT01467453</nct_id>
  </id_info>
  <brief_title>Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      The study objective is to investigate the clinical applicability of continuous IOP
      measurement using TS with radio transmission over 24 hours.

        -  Trial with medical device
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date>December 2012</completion_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glaucoma</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Triggerfish</intervention_name>
    <description>The Triggerfish is a contact lens with an embedded sensor to track changes in intraocular pressure during a period of 24 hours.</description>
    <other_name>Triggerfish, SENSIMED AG, Route de Chavannes 37, 1007 Lausanne, Switzerland</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with a diagnosis of glaucoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Clinical diagnosis of glaucoma

        Exclusion criteria:

          -  Other opticus neuropathy than glaucoma

          -  Corneal abnormalities (e.g. scaring)

          -  Dry eye disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph Kniestedt, Assistant Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Ophtalmic Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Ophthalmic Clinic</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <lastchanged_date>November 14, 2011</lastchanged_date>
  <firstreceived_date>November 3, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
